Ryan Udell Discusses Life Sciences Landscape in Boston, Philadelphia
Industry experts and consultants in the pharma and bio-technology fields are observing a trend of migration to Boston, Massachusetts, based on the city's friendly relationship with its corporate base.
Ryan Udell, Partner and Co-Chair of the Corporate and Securities Group, is an Advisory Board member of the Life Sciences Collaborative, a Philly-founded industry group that has recently expanded north. Quoted in The Philadelphia Inquirer, he noted that the topic of Philly vs. Boston "is near and dear to the Life Sciences Collaborative" and that "[the organization] intend[s] to have a Philly/Boston summit of sorts...to discuss how Philly can learn from Boston's successes and vice versa."
The entire article is available here.
If you would like to receive additional news alerts, event notifications, or correspondences pertaining to this and other industry-specific topics, please sign up by visiting the Contact Us page. Be sure to provide your contact information, including email address, and list the areas of practice or industries for which you would like to receive information.
This correspondence should not be construed as legal advice or legal opinion on any specific facts or circumstances. The contents are intended for general informational purposes only, and you are urged to consult a lawyer concerning your own situation with any specific legal question you may have.